chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Induration, Pain in extremity, Pyrexia, Urine analysis normal
Clinical narrative: Information has been received from a nurse practitioner concerning a 66 year old female with egg allergy, sulfonamide allergy and doxycycline allergy and a history of right kidney removing who on 06-FEB-2009 was vaccinated subcutaneously into left arm with a 0.65 ml dose of ZOSTAVAX (Merck) (expiration date 01-MAR-2009, lot# 658863/1414U). There was no other vaccine administered. On 09-FEB-2009 the patient went to her primary health care provider with complaints of fever, chills, low back pain on left and right side. While at the provider's office it was found that the patient had a no shingles rash, 3 by 1 inch erythematous patch, induration, inferior to the left deltoid. The patient was diagnosed with cellulitis and was treated with KEFLEX. At the time of the report, the patient had recovered. Follow up information received from a nurse practitioner via medical records indicated that the patient was a female business owner with no acute illness, who on 06-FEB-2009 was vaccinated with a first dose of ZOSTAVAX (Merck) into her left arm. Concomitant therapy included LEVOXYL, PRILOSEC, simvastatin (manufacturer unknown), lisinopril (manufacturer unknown) and aspirin. The patient came to the physician's office on 09-FEB-2009 and reported that she had chills and some right and left lower back pain since 07-FEB-2009. Her left arm had been sore as well. The patient had presented with fever and back pain. On 09-FEB-2009 the patient was diagnosed with cellulitis by her primary physician; her blood pressure was 118/70 and also presented with a fever ( temperature was 99, units not reported), patient's urine was clear; she had a 3 inch by 1 inch patch of erythema and induration just inferior to the vaccination site on the left deltoid. No shingles rash. The back had no CVA tenderness. The physician's assessment was cellulitis left arm status post-injection; the patient was prescribed KEFLEX 500 mg TID x 5 days, ADVIL or ALEVE as directed. The reporter considered cellulitis, low back pain, chills and fever to be other important medical events. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Human papilloma virus test positive, Menstrual disorder, Papilloma viral infection, Precancerous cells present
Clinical narrative: Information has been received via the internet from a consumer concerning his or her daughter who was vaccinated with 2 doses of GARDASIL (lot number, date, route and site not reported). Approximately a year later the patient had tested positive for high-risk HPV. The patient suffered SEVERE side effects from them which incapacitated her for 2 1/2 months. The patient continued to experience menstrual problems even though it had been over a year. At the time of the report, the patient had precancerous, high-risk HPV. It was reported that the reporter believe that the patient's HPV was the result of the vaccines because the patient did not have HPV when she received the vaccines. Severe side effects and menstrual problems were considered to be disabling. This is one of several reports received from the same source. Attempts to verify the existence of an identifiable patient have been unsuccessful.
Sex: U
Vaccine: HPV4
Symptoms: Death
Clinical narrative: Information has been received from a consumer via an internet newspaper concerning a patient who on an unspecified date was vaccinated with a dose of GARDASIL. It was reported that a parent can be guilty because if he had known about the side effects, then he might not have allowed the pediatrician to vaccinate the child, which resulted in death (cause of death unspecified). It was unknown if the patient sought medical attention. It was also reported that polysorbato 80 or tween 80 that is a chemical that causes infertility in mice and aluminum which is neurological toxin are in GARDASIL. This is one of several reports from the same source. Additional information is not expected.
Age: 0.38
Sex: F
Vaccine: RV5
Symptoms: Aspiration bone marrow abnormal, Barium enema normal, Blood creatinine normal, Blood lactate dehydrogenase increased, Blood product transfusion
Clinical narrative: Information has been received from a published article, title as stated above concerning a 20 weeks old previously healthy female who presented to the emergency room, with low grade fever, hematochezia and non-bloody emesis that lasted for about 48 hours. She had received her second set of immunizations; including oral ROTATEQ one week prior to presentation. Physical exam revealed multiple petechiae over her entire body but no visceromegaly. Barium enema was negative for intussusception, although stool enzyme immunoassay was positive for rotavirus. Platelet count was found to be 19,000/cmm, hemoglobin was 6.4 g/dl, and white blood cell count was 8,300/cmm with normal differentials. On peripheral blood smear she had normochromic, normocytic  red blood cells with polychromasia and occasional schistocytes, giant platelets and no blasts. Direct coomb's test was negative, blood urea nitrogen, serum creatinine, coagulation studies, compliment factors, liver functions and immunoglobulin levels were all within normal limits, lactate dehydrogenase was 399 U/L; serologies for HIV, Epstein-Barr virus, cytomegalovirus and parvovirus B-19 were negative. Her bone marrow showed normal cellularity with increased number of megakaryocytes. She was stabilized with packed red blood cell transfusion and intravenous fluids, but the platelet count dropped down to 3,000/cmm. Thrombotic Thrombocytopenic purpura was ruled out with normal ADAMTS-13 levels, though fresh frozen plasma was given prior to this. Patient was given 1g/kg body weight, infusion of IVIG in two divided doses and platelet counts rose up to 32,000/cmm within the next 2 days. She was discharged home with recommendations for close follow up. She required three more doses of IVIG for recurrent drop in platelet counts, over the next 2 months, with a good response each time; while no bleeding was reported. Following the fourth dose of IVIG her platelet count increased to 192,000/cmm and subsequently remained over 150,000/cmm without intervention. After 4 months of follow up, she continued to do well and her hemoglobin had remained stable. She was advised not to receive the third dose of ROTATEQ. The development of serious rotavirus gastroenteritis in a partially vaccinated infant was rare but was known to occur. The development of immune thrombocytopenic purpura in this infant might have been associated with rotavirus infection, although this could have been an incidental finding. The prevalence of rotavirus infection was very high worldwide and it would be of interest to perform analysis examining platelet counts and hemoglobin in infants diagnosed with acute rotavirus infections. Additional information has been requested.
Age: 0.38
Sex: F
Vaccine: RV5
Symptoms: Blood smear test abnormal, Blood urea normal, Coagulation test normal, Complement factor normal, Coombs direct test negative
Clinical narrative: Information has been received from a published article, title as stated above concerning a 20 weeks old previously healthy female who presented to the emergency room, with low grade fever, hematochezia and non-bloody emesis that lasted for about 48 hours. She had received her second set of immunizations; including oral ROTATEQ one week prior to presentation. Physical exam revealed multiple petechiae over her entire body but no visceromegaly. Barium enema was negative for intussusception, although stool enzyme immunoassay was positive for rotavirus. Platelet count was found to be 19,000/cmm, hemoglobin was 6.4 g/dl, and white blood cell count was 8,300/cmm with normal differentials. On peripheral blood smear she had normochromic, normocytic  red blood cells with polychromasia and occasional schistocytes, giant platelets and no blasts. Direct coomb's test was negative, blood urea nitrogen, serum creatinine, coagulation studies, compliment factors, liver functions and immunoglobulin levels were all within normal limits, lactate dehydrogenase was 399 U/L; serologies for HIV, Epstein-Barr virus, cytomegalovirus and parvovirus B-19 were negative. Her bone marrow showed normal cellularity with increased number of megakaryocytes. She was stabilized with packed red blood cell transfusion and intravenous fluids, but the platelet count dropped down to 3,000/cmm. Thrombotic Thrombocytopenic purpura was ruled out with normal ADAMTS-13 levels, though fresh frozen plasma was given prior to this. Patient was given 1g/kg body weight, infusion of IVIG in two divided doses and platelet counts rose up to 32,000/cmm within the next 2 days. She was discharged home with recommendations for close follow up. She required three more doses of IVIG for recurrent drop in platelet counts, over the next 2 months, with a good response each time; while no bleeding was reported. Following the fourth dose of IVIG her platelet count increased to 192,000/cmm and subsequently remained over 150,000/cmm without intervention. After 4 months of follow up, she continued to do well and her hemoglobin had remained stable. She was advised not to receive the third dose of ROTATEQ. The development of serious rotavirus gastroenteritis in a partially vaccinated infant was rare but was known to occur. The development of immune thrombocytopenic purpura in this infant might have been associated with rotavirus infection, although this could have been an incidental finding. The prevalence of rotavirus infection was very high worldwide and it would be of interest to perform analysis examining platelet counts and hemoglobin in infants diagnosed with acute rotavirus infections. Additional information has been requested.
Age: 0.38
Sex: F
Vaccine: RV5
Symptoms: Cytomegalovirus test negative, Differential white blood cell count normal, Epstein-Barr virus test negative, Gastroenteritis rotavirus, HIV test negative
Clinical narrative: Information has been received from a published article, title as stated above concerning a 20 weeks old previously healthy female who presented to the emergency room, with low grade fever, hematochezia and non-bloody emesis that lasted for about 48 hours. She had received her second set of immunizations; including oral ROTATEQ one week prior to presentation. Physical exam revealed multiple petechiae over her entire body but no visceromegaly. Barium enema was negative for intussusception, although stool enzyme immunoassay was positive for rotavirus. Platelet count was found to be 19,000/cmm, hemoglobin was 6.4 g/dl, and white blood cell count was 8,300/cmm with normal differentials. On peripheral blood smear she had normochromic, normocytic  red blood cells with polychromasia and occasional schistocytes, giant platelets and no blasts. Direct coomb's test was negative, blood urea nitrogen, serum creatinine, coagulation studies, compliment factors, liver functions and immunoglobulin levels were all within normal limits, lactate dehydrogenase was 399 U/L; serologies for HIV, Epstein-Barr virus, cytomegalovirus and parvovirus B-19 were negative. Her bone marrow showed normal cellularity with increased number of megakaryocytes. She was stabilized with packed red blood cell transfusion and intravenous fluids, but the platelet count dropped down to 3,000/cmm. Thrombotic Thrombocytopenic purpura was ruled out with normal ADAMTS-13 levels, though fresh frozen plasma was given prior to this. Patient was given 1g/kg body weight, infusion of IVIG in two divided doses and platelet counts rose up to 32,000/cmm within the next 2 days. She was discharged home with recommendations for close follow up. She required three more doses of IVIG for recurrent drop in platelet counts, over the next 2 months, with a good response each time; while no bleeding was reported. Following the fourth dose of IVIG her platelet count increased to 192,000/cmm and subsequently remained over 150,000/cmm without intervention. After 4 months of follow up, she continued to do well and her hemoglobin had remained stable. She was advised not to receive the third dose of ROTATEQ. The development of serious rotavirus gastroenteritis in a partially vaccinated infant was rare but was known to occur. The development of immune thrombocytopenic purpura in this infant might have been associated with rotavirus infection, although this could have been an incidental finding. The prevalence of rotavirus infection was very high worldwide and it would be of interest to perform analysis examining platelet counts and hemoglobin in infants diagnosed with acute rotavirus infections. Additional information has been requested.
Age: 0.38
Sex: F
Vaccine: RV5
Symptoms: Haematochezia, Haemoglobin decreased, Immunoglobulin therapy, Immunoglobulins normal, Liver function test normal
Clinical narrative: Information has been received from a published article, title as stated above concerning a 20 weeks old previously healthy female who presented to the emergency room, with low grade fever, hematochezia and non-bloody emesis that lasted for about 48 hours. She had received her second set of immunizations; including oral ROTATEQ one week prior to presentation. Physical exam revealed multiple petechiae over her entire body but no visceromegaly. Barium enema was negative for intussusception, although stool enzyme immunoassay was positive for rotavirus. Platelet count was found to be 19,000/cmm, hemoglobin was 6.4 g/dl, and white blood cell count was 8,300/cmm with normal differentials. On peripheral blood smear she had normochromic, normocytic  red blood cells with polychromasia and occasional schistocytes, giant platelets and no blasts. Direct coomb's test was negative, blood urea nitrogen, serum creatinine, coagulation studies, compliment factors, liver functions and immunoglobulin levels were all within normal limits, lactate dehydrogenase was 399 U/L; serologies for HIV, Epstein-Barr virus, cytomegalovirus and parvovirus B-19 were negative. Her bone marrow showed normal cellularity with increased number of megakaryocytes. She was stabilized with packed red blood cell transfusion and intravenous fluids, but the platelet count dropped down to 3,000/cmm. Thrombotic Thrombocytopenic purpura was ruled out with normal ADAMTS-13 levels, though fresh frozen plasma was given prior to this. Patient was given 1g/kg body weight, infusion of IVIG in two divided doses and platelet counts rose up to 32,000/cmm within the next 2 days. She was discharged home with recommendations for close follow up. She required three more doses of IVIG for recurrent drop in platelet counts, over the next 2 months, with a good response each time; while no bleeding was reported. Following the fourth dose of IVIG her platelet count increased to 192,000/cmm and subsequently remained over 150,000/cmm without intervention. After 4 months of follow up, she continued to do well and her hemoglobin had remained stable. She was advised not to receive the third dose of ROTATEQ. The development of serious rotavirus gastroenteritis in a partially vaccinated infant was rare but was known to occur. The development of immune thrombocytopenic purpura in this infant might have been associated with rotavirus infection, although this could have been an incidental finding. The prevalence of rotavirus infection was very high worldwide and it would be of interest to perform analysis examining platelet counts and hemoglobin in infants diagnosed with acute rotavirus infections. Additional information has been requested.
Age: 0.38
Sex: F
Vaccine: RV5
Symptoms: Megakaryocytes increased, Packed red blood cell transfusion, Parvovirus B19 test negative, Petechiae, Platelet count decreased
Clinical narrative: Information has been received from a published article, title as stated above concerning a 20 weeks old previously healthy female who presented to the emergency room, with low grade fever, hematochezia and non-bloody emesis that lasted for about 48 hours. She had received her second set of immunizations; including oral ROTATEQ one week prior to presentation. Physical exam revealed multiple petechiae over her entire body but no visceromegaly. Barium enema was negative for intussusception, although stool enzyme immunoassay was positive for rotavirus. Platelet count was found to be 19,000/cmm, hemoglobin was 6.4 g/dl, and white blood cell count was 8,300/cmm with normal differentials. On peripheral blood smear she had normochromic, normocytic  red blood cells with polychromasia and occasional schistocytes, giant platelets and no blasts. Direct coomb's test was negative, blood urea nitrogen, serum creatinine, coagulation studies, compliment factors, liver functions and immunoglobulin levels were all within normal limits, lactate dehydrogenase was 399 U/L; serologies for HIV, Epstein-Barr virus, cytomegalovirus and parvovirus B-19 were negative. Her bone marrow showed normal cellularity with increased number of megakaryocytes. She was stabilized with packed red blood cell transfusion and intravenous fluids, but the platelet count dropped down to 3,000/cmm. Thrombotic Thrombocytopenic purpura was ruled out with normal ADAMTS-13 levels, though fresh frozen plasma was given prior to this. Patient was given 1g/kg body weight, infusion of IVIG in two divided doses and platelet counts rose up to 32,000/cmm within the next 2 days. She was discharged home with recommendations for close follow up. She required three more doses of IVIG for recurrent drop in platelet counts, over the next 2 months, with a good response each time; while no bleeding was reported. Following the fourth dose of IVIG her platelet count increased to 192,000/cmm and subsequently remained over 150,000/cmm without intervention. After 4 months of follow up, she continued to do well and her hemoglobin had remained stable. She was advised not to receive the third dose of ROTATEQ. The development of serious rotavirus gastroenteritis in a partially vaccinated infant was rare but was known to occur. The development of immune thrombocytopenic purpura in this infant might have been associated with rotavirus infection, although this could have been an incidental finding. The prevalence of rotavirus infection was very high worldwide and it would be of interest to perform analysis examining platelet counts and hemoglobin in infants diagnosed with acute rotavirus infections. Additional information has been requested.
Age: 0.38
Sex: F
Vaccine: RV5
Symptoms: Platelet morphology abnormal, Polychromasia, Pyrexia, Red blood cell schistocytes present, Rotavirus infection
Clinical narrative: Information has been received from a published article, title as stated above concerning a 20 weeks old previously healthy female who presented to the emergency room, with low grade fever, hematochezia and non-bloody emesis that lasted for about 48 hours. She had received her second set of immunizations; including oral ROTATEQ one week prior to presentation. Physical exam revealed multiple petechiae over her entire body but no visceromegaly. Barium enema was negative for intussusception, although stool enzyme immunoassay was positive for rotavirus. Platelet count was found to be 19,000/cmm, hemoglobin was 6.4 g/dl, and white blood cell count was 8,300/cmm with normal differentials. On peripheral blood smear she had normochromic, normocytic  red blood cells with polychromasia and occasional schistocytes, giant platelets and no blasts. Direct coomb's test was negative, blood urea nitrogen, serum creatinine, coagulation studies, compliment factors, liver functions and immunoglobulin levels were all within normal limits, lactate dehydrogenase was 399 U/L; serologies for HIV, Epstein-Barr virus, cytomegalovirus and parvovirus B-19 were negative. Her bone marrow showed normal cellularity with increased number of megakaryocytes. She was stabilized with packed red blood cell transfusion and intravenous fluids, but the platelet count dropped down to 3,000/cmm. Thrombotic Thrombocytopenic purpura was ruled out with normal ADAMTS-13 levels, though fresh frozen plasma was given prior to this. Patient was given 1g/kg body weight, infusion of IVIG in two divided doses and platelet counts rose up to 32,000/cmm within the next 2 days. She was discharged home with recommendations for close follow up. She required three more doses of IVIG for recurrent drop in platelet counts, over the next 2 months, with a good response each time; while no bleeding was reported. Following the fourth dose of IVIG her platelet count increased to 192,000/cmm and subsequently remained over 150,000/cmm without intervention. After 4 months of follow up, she continued to do well and her hemoglobin had remained stable. She was advised not to receive the third dose of ROTATEQ. The development of serious rotavirus gastroenteritis in a partially vaccinated infant was rare but was known to occur. The development of immune thrombocytopenic purpura in this infant might have been associated with rotavirus infection, although this could have been an incidental finding. The prevalence of rotavirus infection was very high worldwide and it would be of interest to perform analysis examining platelet counts and hemoglobin in infants diagnosed with acute rotavirus infections. Additional information has been requested.
Age: 0.38
Sex: F
Vaccine: RV5
Symptoms: Stool analysis abnormal, Vomiting, White blood cell count normal
Clinical narrative: Information has been received from a published article, title as stated above concerning a 20 weeks old previously healthy female who presented to the emergency room, with low grade fever, hematochezia and non-bloody emesis that lasted for about 48 hours. She had received her second set of immunizations; including oral ROTATEQ one week prior to presentation. Physical exam revealed multiple petechiae over her entire body but no visceromegaly. Barium enema was negative for intussusception, although stool enzyme immunoassay was positive for rotavirus. Platelet count was found to be 19,000/cmm, hemoglobin was 6.4 g/dl, and white blood cell count was 8,300/cmm with normal differentials. On peripheral blood smear she had normochromic, normocytic  red blood cells with polychromasia and occasional schistocytes, giant platelets and no blasts. Direct coomb's test was negative, blood urea nitrogen, serum creatinine, coagulation studies, compliment factors, liver functions and immunoglobulin levels were all within normal limits, lactate dehydrogenase was 399 U/L; serologies for HIV, Epstein-Barr virus, cytomegalovirus and parvovirus B-19 were negative. Her bone marrow showed normal cellularity with increased number of megakaryocytes. She was stabilized with packed red blood cell transfusion and intravenous fluids, but the platelet count dropped down to 3,000/cmm. Thrombotic Thrombocytopenic purpura was ruled out with normal ADAMTS-13 levels, though fresh frozen plasma was given prior to this. Patient was given 1g/kg body weight, infusion of IVIG in two divided doses and platelet counts rose up to 32,000/cmm within the next 2 days. She was discharged home with recommendations for close follow up. She required three more doses of IVIG for recurrent drop in platelet counts, over the next 2 months, with a good response each time; while no bleeding was reported. Following the fourth dose of IVIG her platelet count increased to 192,000/cmm and subsequently remained over 150,000/cmm without intervention. After 4 months of follow up, she continued to do well and her hemoglobin had remained stable. She was advised not to receive the third dose of ROTATEQ. The development of serious rotavirus gastroenteritis in a partially vaccinated infant was rare but was known to occur. The development of immune thrombocytopenic purpura in this infant might have been associated with rotavirus infection, although this could have been an incidental finding. The prevalence of rotavirus infection was very high worldwide and it would be of interest to perform analysis examining platelet counts and hemoglobin in infants diagnosed with acute rotavirus infections. Additional information has been requested.
Age: 0.16
Sex: M
Vaccine: DTAPIPVHIB, RV5
Symptoms: Abdominal pain upper, Crying, Culture stool negative, Haematochezia, Rotavirus test negative
Clinical narrative: Information has been received from a registered nurse and a medical assistant concerning an 8 weeks old male patient who on 04-MAR-2010 was vaccinated with the first dose of ROTATEQ (Lot#664650/1098Y). Concomitant vaccine included PENTACEL (Lot#C3542A). The medical assistant reported that on 04-MAR-2010, the patient's parents reported that the patient was crying and had stomach pain throughout the night. On 11-MAR-2010, the patient was seen in the physician's office, it was reported that the patient had blood in his stool. A stool culture was performed and the result was negative for rotavirus. On an unspecified date, the crying and stomach pain subsided. On 16-MAR-2010, the patient's parent reported that the patient continued with blood in his stool. At the time of the report, the patient had not recovered. Upon internal review, blood in stool was determined to be an other important medical event. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None.
Age: 2.0
Sex: M
Vaccine: FLU(H1N1), FLU3
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None.
Age: 2.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None.
Age: 2.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None.
Age: 1.8
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None.
Age: 17.0
Sex: M
Vaccine: MNQ
Symptoms: Urticaria
Clinical narrative: 3/18/10 resident given MENACTRA vaccine left arm. Within 5 - 10 minutes later reported hives right cheek - 2 hives noticed (R) cheek. No difficulty breathing or other symptoms mentioned. BENADRYL given - symptoms resolved.
Age: 1.54
Sex: M
Vaccine: DTAP, FLU(H1N1), FLU3, HIBV
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, VARCEL
Symptoms: Dizziness, Headache, Sinus disorder
Clinical narrative: C/o headache dizzy for a couple of weeks. Onset day after receiving vaccines 3/5/10. Tx with 200mg Motrin every 6-8 hrs. Taken to Doctor 3/11/10 told sinus problems and prescribed Sildec Pe- DM calling today because still having headaches. Advised to notify Doctor.
Age: 38.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Injection site pain, Neck pain, Thinking abnormal, Vision blurred
Clinical narrative: Within 20-30 min after injection while drive, blurred vision unable to think clearly, 5-10 after that felt like pins and needles on arm where injection rec'd travels to neck. Drove home during this episode, then went to ER.
Age: 1.54
Sex: M
Vaccine: DTAP, FLU(H1N1), FLU3, HIBV
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None stated.
Age: 1.3
Sex: M
Vaccine: FLU(H1N1), FLU3, HIBV, MMR, VARCEL
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: none
Age: 24.0
Sex: M
Vaccine: TDAP
Symptoms: Abdominal pain upper, Nausea, Pyrexia, Retching
Clinical narrative: Fever of 101 degrees F, nausea, stomach cramps, dry heaves. Lasted 24 hours. Self-care.  Patient believes illness was result of Tdap.
Age: 3.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: Gave Novartis H1N1 Vaccine outside FDA approved age range
Age: 30.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Erythema, Feeling hot, Oedema peripheral, Tenderness
Clinical narrative: Sixth booster anthrax given Rt deltoid on 16 Mar 2010.  Following morning pt noticed Rt arm swollen, warm, red and tender.  18 Mar 2010 arm is better, still still slightly warm and swollen.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Body temperature increased, Injection site erythema, Injection site induration, Injection site pruritus, Injection site warmth
Clinical narrative: Area size of credit card on upper L arm, red, warm, hard to touch, itching - Sneezing, temp 99-101 degrees - Alternating TYLENOL/ Ibuprofen - BENADRYL. Mother states it is the arm client pulled away during vaccination.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Sneezing
Clinical narrative: Area size of credit card on upper L arm, red, warm, hard to touch, itching - Sneezing, temp 99-101 degrees - Alternating TYLENOL/ Ibuprofen - BENADRYL. Mother states it is the arm client pulled away during vaccination.
Age: 1.0
Sex: M
Vaccine: FLU(H1N1), FLU3
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None stated.
Age: 0.92
Sex: F
Vaccine: FLU(H1N1), FLU3, HEP
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None stated.
Age: 32.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Dizziness, Echocardiogram, Electrocardiogram, Swelling face, Throat tightness
Clinical narrative: Felt face was swelling and throat was closing.  Felt dizzy.
Age: 77.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Injection site swelling, Lip swelling
Clinical narrative: LIP AND INJECTION SITE EDEMA BENADRYL 25MG Q6HRS
Age: 0.91
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 0.78
Sex: F
Vaccine: FLU(H1N1), HEP
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None stated.
Age: 23.0
Sex: M
Vaccine: ANTH, FLU3, TYP
Symptoms: Dizziness, Dyspnoea, Muscle contractions involuntary
Clinical narrative: Initially it appeared as though patient was going to pass out after recieving immunizations, and he reported feeling like he might.  He was moved to a reclining chair with a cold pack behind his neck, and his boot laces and belt were loosened as is usually done when patients pass out or may pass out.  After approximately 10 minutes he began involuntary contractions and reported labored breathing.  An ambulance was immediately called at this point and an IV with normal saline given prior to their arrival.  Immediately taken to Emergency Room upon the arrival of the ambulance.
Age: 2.0
Sex: F
Vaccine: FLUN(H1N1), HEP
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None stated.
Age: 0.62
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Inappropriate schedule of drug administration, Unevaluable event
Clinical narrative: None stated.
Age: 0.62
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 32.0
Sex: F
Vaccine: TDAP
Symptoms: Arthroscopic surgery, Bone disorder, Drug administered at inappropriate site, Hypoaesthesia, Joint range of motion decreased
Clinical narrative: Severe pain, decreased ROM, bone damage because shot was placed in shoulder. Received physical therapy and arthroscopic surgery on 10/16/2007. Continues to have pain in shoulder and numbness to hand to the present time.
Age: 32.0
Sex: F
Vaccine: TDAP
Symptoms: Musculoskeletal pain, Nuclear magnetic resonance imaging, Pain
Clinical narrative: Severe pain, decreased ROM, bone damage because shot was placed in shoulder. Received physical therapy and arthroscopic surgery on 10/16/2007. Continues to have pain in shoulder and numbness to hand to the present time.
Age: 0.63
Sex: M
Vaccine: FLU(H1N1), FLU3
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 0.55
Sex: F
Vaccine: DTAP, FLU(H1N1), FLU3, HIBV, PNC
Symptoms: Unevaluable event
Clinical narrative: None.
Age: 0.56
Sex: F
Vaccine: DTAPIPVHIB, FLU(H1N1), FLU3, PNC, RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None stated.
Age: 4.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Unevaluable event
Clinical narrative: None.
Age: 3.0
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: Unevaluable event
Clinical narrative: "None reported".
Age: 2.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Unevaluable event
Clinical narrative: None.
Age: 2.0
Sex: F
Vaccine: FLU(H1N1), FLU3
Symptoms: No adverse event
Clinical narrative: none
Age: 19.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Blood pressure, Blood pressure increased, Dizziness, Stress
Clinical narrative: Pt reported feeling dizzy. BP on thigh 140/100. Not diabetic. Pt took Sprite & advised to eat/drink & call primary care physician. Pt dealing with a lot of stress at court & thinks might be related to stress.
Age: 17.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Pruritus, Rash, Skin warm
Clinical narrative: Developed rash on both cheeks and around eyes. Hot and itchy. No hives, no difficulty breathing, no fever. States she feels fine. Referred to family physician. Appointment was made by parent, but cancelled because rash had subsided within a few hours after being reported.
Age: 12.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Syncope
Clinical narrative: Fainting.
Age: 10.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Hypoaesthesia
Clinical narrative: left arm numbness
Age: 21.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Hypoaesthesia, Injection site erythema, Oedema peripheral, Pain
Clinical narrative: left arm numb, left hand numb, pain, aching, hand swelling. Injection site reddened, doctor notified.
Age: 13.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Injection site haematoma
Clinical narrative: Left deltoid hematoma. Ice applied.
Age: 11.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Syncope
Clinical narrative: Fainting.
Age: 30.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Dizziness, Drug exposure during pregnancy, Pharyngeal oedema
Clinical narrative: Dizzy, "feels like throat is swelling up" .Refused oral BENADRYL - verbal order from OBGYN. Refused to go to ER.
Age: 13.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Pruritus
Clinical narrative: Itching left hand.
Age: 13.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Asthenia, Nausea
Clinical narrative: Generalized weakness, nausea.
Age: 12.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Body temperature decreased, Dizziness
Clinical narrative: dizzy T96 degree
Age: 11.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Feeling hot
Clinical narrative: C/o feeling "hot" T 97 degrees.
Age: 6.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Syncope
Clinical narrative: Faint
Age: 14.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Convulsion
Clinical narrative: Seizure activity.
Age: 10.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Left deltoid red, itching. BENADRYL 25mg po one given.
Age: 9.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Nausea, Pallor
Clinical narrative: Nausea, pale color of skin
Age: 9.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Injection site erythema
Clinical narrative: Redness of left deltoid, ice applied.
Age: 13.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Redness (3 inch x 3 inch), warmth of left deltoid. Ice applied.
Age: 7.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Nausea
Clinical narrative: nausea
Age: 12.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Body temperature decreased, Headache, Nausea
Clinical narrative: Nausea, headache. T 96.8 degrees. Allergy-peanuts.
Age: 44.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Injection site erythema, Injection site swelling, Pruritus
Clinical narrative: Left deltoid red, swollen - no itching of arm. Itching abdomen. BENADRYL 25 mg po given.
Age: 20.0
Sex: M
Vaccine: FLUX(H1N1)
Symptoms: Rash generalised, Rash pruritic
Clinical narrative: "I got an H1N1 vaccination & got an itchy rash all over my body lasting 3 weeks on going. Other students have told me they had the same reaction."
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Chest pain, Dizziness, Dyspnoea, Rash, Throat tightness
Clinical narrative: Pt had rash on chest 5 min after injection of seasonal flu. Had difficulty breathing c/o chest pain. After 5 more min rash was gone but pt c/o dizziness and clogged throat. EMT's called. Taken to hospital.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Injection site erythema, Injection site swelling, Injection site warmth, Pain in extremity
Clinical narrative: This am - arm sore noticed redness around 12:00pm - Here at 1:00. Redness, heat & swelling covering approximately 1/2 of upper arm & deltoid. Advised Ibuprofen, Benadryl and cold compress.
Age: 5.0
Sex: F
Vaccine: FLU3
Symptoms: Crying, Injection site erythema, Injection site swelling
Clinical narrative: Pt received flu shot and w/in a few mins R shoulder became red and swollen. Pt was crying but no c/o SOB, dizziness, or pain. Parents refused medical care @ clinic site
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Blister, Dermatitis, Paraesthesia, Rash papular, Rash pruritic
Clinical narrative: 21 y/o male developed mildly pruritic pustular eruptions over UE and torso onset 8 days following vaccinations for SP, typhoid, AVA given 3/9/2010. No other systemic symptoms. Medically evaluated 3/19 at which time VSN, exam revealed erythematous papules over b/l upper arms, chest, most on back, few vesicles, few pustules, normal vaccine site on the right shoulder; no ecchymosis. Dx was dermatitis. Rx Allegra, ,Benadryl, Voltaren. Derm photos reviewed by director-clinical presentation and photos c/w non-IgE mediated reaction associated with SPV. By 3/22, SM improved, VHC recommended medical reactive exemption for future SPV in pre-exposure setting. Symptoms: Rash oth nonspecific skin eruption (782.1), Disturbance of skin sensation (782.0).
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP
Symptoms: Rash pustular
Clinical narrative: 21 y/o male developed mildly pruritic pustular eruptions over UE and torso onset 8 days following vaccinations for SP, typhoid, AVA given 3/9/2010. No other systemic symptoms. Medically evaluated 3/19 at which time VSN, exam revealed erythematous papules over b/l upper arms, chest, most on back, few vesicles, few pustules, normal vaccine site on the right shoulder; no ecchymosis. Dx was dermatitis. Rx Allegra, ,Benadryl, Voltaren. Derm photos reviewed by director-clinical presentation and photos c/w non-IgE mediated reaction associated with SPV. By 3/22, SM improved, VHC recommended medical reactive exemption for future SPV in pre-exposure setting. Symptoms: Rash oth nonspecific skin eruption (782.1), Disturbance of skin sensation (782.0).
Age: 14.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Headache, Pain in extremity
Clinical narrative: Ten minutes after receiving vaccination patient reported headache and sore arm. Ice pack applied parent called.
Age: 9.0
Sex: F
Vaccine: FLU3, FLUN(H1N1)
Symptoms: Atrial flutter, Dizziness, Electrocardiogram abnormal, Intensive care, Palpitations
Clinical narrative: Pt had dizziness and palpitations several hours post H1N1 and Seasonal Flu vaccination. Was admitted to ICU for atrial flutter.
Age: 12.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Patient c/o itching and redness at injection site on left shoulder. Red area 4 cm diameter at injection site. No other complaints cool compress applied redness spread to neck shoulder and cheeks 911 called. They assessed and released patient to parent advised to see pediatrician.
Age: 16.0
Sex: F
Vaccine: HEPA, MNQ, VARCEL
Symptoms: Erythema, Pain in extremity, Skin infection
Clinical narrative: Mother called 3-22-10 @ 11:35AM to report she took child to ER on 3-21-10. Mother reports child woke 3-21-10 with increase redness and pain to L arm. Area of redness "the size of a golf ball." Patient was Rx antibiotic for "skin infection". Denies fever.
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Blood test, Cheilitis, Dysphonia, Erythema, Eye swelling
Clinical narrative: Immediately following the vaccine, he compained his throat hurt and it was tight.  He was given water and Dr. checked his throat, nothing noted.  He was given more water and we checked out and left the office.  About 3-5 minutes later, his eyes were swollen almost shut, ears, face and lips were bright red, and lips were swollen as well.  He had a rash from head to toe, and his voice was very hoarse. He was also shaking. We drove back to the Dr. office about 5 minutes later, where the doctor kept him under his supervision until the ambulance arrived.  At the Emergency room, he was given a steroid and Benadryl as well as a prescription for an EPI pen to be carried with him.
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Immediate post-injection reaction, Lip swelling, Oropharyngeal pain, Rash generalised, Throat tightness
Clinical narrative: Immediately following the vaccine, he compained his throat hurt and it was tight.  He was given water and Dr. checked his throat, nothing noted.  He was given more water and we checked out and left the office.  About 3-5 minutes later, his eyes were swollen almost shut, ears, face and lips were bright red, and lips were swollen as well.  He had a rash from head to toe, and his voice was very hoarse. He was also shaking. We drove back to the Dr. office about 5 minutes later, where the doctor kept him under his supervision until the ambulance arrived.  At the Emergency room, he was given a steroid and Benadryl as well as a prescription for an EPI pen to be carried with him.
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Tremor
Clinical narrative: Immediately following the vaccine, he compained his throat hurt and it was tight.  He was given water and Dr. checked his throat, nothing noted.  He was given more water and we checked out and left the office.  About 3-5 minutes later, his eyes were swollen almost shut, ears, face and lips were bright red, and lips were swollen as well.  He had a rash from head to toe, and his voice was very hoarse. He was also shaking. We drove back to the Dr. office about 5 minutes later, where the doctor kept him under his supervision until the ambulance arrived.  At the Emergency room, he was given a steroid and Benadryl as well as a prescription for an EPI pen to be carried with him.
Age: 37.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site rash
Clinical narrative: RASH TO INJECTION SITE (LEFT UPPER DELTOID REGION) WHERE SHE RECEIVED FLU VACCINE
Age: 61.0
Sex: F
Vaccine: PPV
Symptoms: Feeling abnormal, Loss of consciousness
Clinical narrative: PATIENT WAS GIVEN PNEUMOVAX 3/19/2010 @ 9:45 AM. AT 9:50 AM, PATIENT C/O "FEELING FUNNY" AND LOST CONSCIOUSNESS FOR 2 MINUTES. AFTER RECOVERING, SHE WAS OBSERVED FOR 2 HOURS AND GIVEN IV FLUID.
Age: 11.0
Sex: F
Vaccine: FLU3, FLUN(H1N1), HPV4, MNQ, TDAP
Symptoms: Asthenia, Skin discolouration, Syncope
Clinical narrative: Patient recieved five vaccines at time of visit. After receiving her vaccines she stated that she felt weak and then she fainted. The patient had not eaten. After the patient came to, she was given juice and pretzels. We kept her until she was feeling better and regained color in her face.
Age: 25.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Developed rash, and pruritis and redness. Took Claritin.
Age: 14.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Petechiae
Clinical narrative: Within 15 minutes of administration Meningococcal vaccine patient exhibited scant generalized petechiae less than 1 mm in diameter on left arm between wrist and deltoid muscle. No respiratory distress or evidence of petechiae on abdomen, or other extremities.  No other untoward signs noted.  Home with Mother, if develops any other symptoms to take to PP or ED. @ 3:00 pm phone call to Mother, "no change in petechiae, no other problems @ this time.  Will follow-up 3/23/10.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Facial palsy
Clinical narrative: Bells Palsy
Age: 13.0
Sex: F
Vaccine: HEPA, HPV4, TDAP, VARCEL
Symptoms: Dehydration, Disorientation, Loss of consciousness, Pallor
Clinical narrative: Patient passed out while waiting to schedule appointment at desk.  She regained full consciousness in 2 minutes.  She was pale and disoriented at first but quickly returned to alert and oriented.  Examined by physician who felt she fainted due to dehydration.
Age: 25.0
Sex: F
Vaccine: TDAP, TYP
Symptoms: Chills, Nausea, Pain
Clinical narrative: PATIENT AWOKE SUFFERING FROM CHILLS, NAUSEA AND BODY ACHES IN THE EARLY MORNING HOURS - CONTINUED THROUGHOUT THE DAY - PT FELT BETTER IN THE AM OF 3/8/2010 FINISHED HER ORAL TYPHOID WITH NO FURTHER ISSUES SUSPECT RXN TO TDAP
Age: 70.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Insomnia, Laboratory test normal, Lichen planus, Rash pruritic, Tremor
Clinical narrative: This 70 year old male patient was administered one dose of the H1N1 Vaccine on 22Dec2009. It is unknown if the patient had any previous allergy or reaction to the H1N1 vaccine. This patient was in for an office visit and reported that he began to experience a severe rash on 23Dec2009 and stated that it was very itchy and he couldn't sleep. The adverse drug reaction (ADR) did not abate after discontinuing the suspected drug. The patient was referred to dermatology and diagnosed with lichen planus probably secondary to vaccination with the H1N1 vaccine. Additional laboratory testing was required because of the ADR and was normal and there was no hematuria.  The patient was treated with topical steroids and antihistamine including  triamcinolone cream (TAC) and Atarax but the Atarax made him shaky.  The patient was also prescribed ultraviolet B light (UVB)  twice a week. The outcome of the events is unknown.
Age: 43.0
Sex: F
Vaccine: TTOX
Symptoms: Abdominal pain, Axillary pain, Back pain, Chest pain, Chills
Clinical narrative: Abdominal pain an hour later headache severe pain in arm. Saturday morning fever, severe pain in arm and under the armpit could not eat or stand, pain in chest and back, chills in head and all over body felt like needle stabs, heart was racing bp 92/62. Severe swelling of site with pain and itching and redness 2 inches a cross my arm hot to the touch.
Age: 43.0
Sex: F
Vaccine: TTOX
Symptoms: Dysstasia, Eating disorder, Headache, Injection site erythema, Injection site pain
Clinical narrative: Abdominal pain an hour later headache severe pain in arm. Saturday morning fever, severe pain in arm and under the armpit could not eat or stand, pain in chest and back, chills in head and all over body felt like needle stabs, heart was racing bp 92/62. Severe swelling of site with pain and itching and redness 2 inches a cross my arm hot to the touch.
Age: 43.0
Sex: F
Vaccine: TTOX
Symptoms: Injection site pruritus, Injection site swelling, Injection site warmth, Pain in extremity, Palpitations
Clinical narrative: Abdominal pain an hour later headache severe pain in arm. Saturday morning fever, severe pain in arm and under the armpit could not eat or stand, pain in chest and back, chills in head and all over body felt like needle stabs, heart was racing bp 92/62. Severe swelling of site with pain and itching and redness 2 inches a cross my arm hot to the touch.
Age: 43.0
Sex: F
Vaccine: TTOX
Symptoms: Paraesthesia, Pyrexia
Clinical narrative: Abdominal pain an hour later headache severe pain in arm. Saturday morning fever, severe pain in arm and under the armpit could not eat or stand, pain in chest and back, chills in head and all over body felt like needle stabs, heart was racing bp 92/62. Severe swelling of site with pain and itching and redness 2 inches a cross my arm hot to the touch.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Computerised tomogram normal, Electroencephalogram normal, Endotracheal intubation, Epilepsy, Grand mal convulsion
Clinical narrative: 30-45 minute simple partial seizures followed by grand mal at about 7:00 pm.  Very challenging post-ictal state requiring sedation and intubation, and 2 day hospital stay.  Second seizure on 2/27/2010 followed same pattern. following
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Laboratory test normal, Movement disorder, Nuclear magnetic resonance imaging normal, Postictal state, Sedation
Clinical narrative: 30-45 minute simple partial seizures followed by grand mal at about 7:00 pm.  Very challenging post-ictal state requiring sedation and intubation, and 2 day hospital stay.  Second seizure on 2/27/2010 followed same pattern. following
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Simple partial seizures, Speech disorder
Clinical narrative: 30-45 minute simple partial seizures followed by grand mal at about 7:00 pm.  Very challenging post-ictal state requiring sedation and intubation, and 2 day hospital stay.  Second seizure on 2/27/2010 followed same pattern. following